Research led by the SKiN Center for Dermatology observed substantial clearance of scalp and body psoriasis and rapid itch reduction in patients treated with roflumilast foam, 0.3%. Findings indicated significantly higher ...
Department of Medicine, University of Toronto, Women's College Hospital, and co-authors have found biologics targeting interleukin (IL)-12, IL-23, or IL-17 were associated with a lower rate of serious infections among older ...
The Hass Avocado Board teamed up with the University of Eastern Finland researchers to examine the relationship between maternal avocado consumption during pregnancy and allergic outcomes in infants. Findings suggest that ...
Chronic rhinosinusitis with nasal polyps presents a substantial clinical burden, affecting nasal airflow, olfactory function, and quality of life. Epithelial barrier dysfunction and type 2 inflammatory responses drive disease ...
An international collaboration of researchers, sponsored by GSK and working on behalf of the ANCHOR-1 and ANCHOR-2 trial investigators, conducted two Phase III clinical trials to evaluate depemokimab, an ultra-long-acting ...
Northwestern University researchers have tested a method to reduce the dreaded nocturnal itch-scratch cycle. Using an AI-trained wearable sensor with vibrating feedback, the device significantly reduced nocturnal scratching ...
Results of a Phase III study conducted by an international team of researchers reveal that mirikizumab is more effective and has a favorable safety profile with fewer serious adverse events compared to a placebo for individuals ...
Aarhus University, Denmark, researchers suggest that recreational fear experiences, such as haunted house attractions, may reduce inflammation in individuals with low-grade inflammation.
Researchers from the National Defense Medical Center in Taiwan have identified an increased risk of psoriasis in patients with cancer undergoing immune checkpoint inhibitor (ICI) treatments, with implications for other immune-related ...
Boston Children's Hospital and Harvard Medical School researchers have discovered a neuroimmune communication pathway that may drive endometriosis-associated pain and lesion growth.
